Innovation, evolution and agility have always been core elements of drug and device development. How else, but through creative, out-of-the-box thinking and a willingness to innovate have we realized everything from mRNA vaccines and organ transplants to immunotherapy and nanomedicine.
Believing in the impossible is at the heart of what we all do. Everyday.
The recent acceleration of innovation within the life science community has heightened challenges that clinical development teams have been facing for decades. Mounting pressure for enhanced patient recruitment and retention, digitization of healthcare data and clinical operations optimization must all fit within the same time and cost constraints.
In this environment, the life science community has sometimes been painted as overly conservative and slow to change, and technology leaders have cast themselves as warriors or saviors.
The reality, however, is that life science leaders and clinical teams don’t object to innovation or big visions. We object to technologies that aren’t grounded in operational reality. We object to big visions that lack clarity and realistic implementation.
Therapeutic advancements always have incredible promise, but we are ethically obligated to constantly balance that promise against risk. Technological advancements within clinical research require the same care.
Today, Cognivia celebrates a decade of research, collaboration, and technological advancements made with care.
What started as an entrepreneurial effort to solve the “unsolvable” problem of placebo response has grown into a company dedicated to creating validated technologies that fill the knowledge gaps in clinical development. A company that helps biotechs and pharmas make better, faster decisions about their portfolios with precision data.
A company that helps save therapies from failing for the wrong reasons.
Our goal is clear: Helping sponsors, CROs and academic centers tackle some of the most challenging barriers that prevent novel drugs from reaching patients.
Our journey began with the exploration of the placebo response in pain management, but it has since expanded into broader application areas. We delved into the characterization of variability on a larger scale—an incredible asset for supporting the implementation of diversity plans, for example, or personalized solutions to enhance patient engagement.
Through the years we have assembled (and retained) an elite team with deep clinical research expertise who challenge each other and grow together. We are also a team of truly dedicated individuals who support each other and our clinical research partners with vision and humility.
Like the broader life science community, we have entered a new era. The core of our vision has remained strong and stable while the application of that vision has been nimble enough to evolve in response to the needs and demands of more real-world data that is more representative of real-world people.
Clinical research teams are navigating a rapidly changing environment and need solutions that are not simply technologically innovative but proven, implementable, and designed to bring new information to the forefront.
In this era of AI-powered tools and healthcare-tech abundance, we aspire to be seen as enablers and disruptors who maximize the power of clinical trials while minimizing the risk and meeting the strictest requirements.
Cognivia stands as the trusted company clinical teams and sponsors can rely on to deliver both innovation and stability.
We achieve better patient outcomes by capturing the differences that make a difference. This ethos defines who we are and guides us as we continue to push the boundaries of what’s possible in clinical trials.
